Developing models to understand infectious diseases.
Official title: Pre-Clinical Models of Infectious Diseases
Funded at Texas Biomedical Research Institute · NIH-11197674 · Data updated 2026-11-12
This study is working on building models that mimic infectious diseases to help researchers find better treatments, so patients can eventually benefit from new therapies that fight these illnesses.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Texas Biomedical Research Institute NIH-funded |
| Lab location | 1 site (San Antonio, United States) |
| Project start | July 15, 2024 |
| Project end | July 14, 2031 |
| Funding year | 2024 |
| Award (this year) | $2,500 |
| NIH project number | 75N93024D00022-0-759302400002-1 |
| Project ID | NIH-11197674 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals affected by infectious diseases or those at high risk of contracting them.
✕Less likely to help
Patients with non-infectious diseases or those who are not at risk for infectious diseases may not receive any benefit from this research.
What this research studies
This research focuses on creating pre-clinical models that simulate infectious diseases to better understand their mechanisms and effects. By using these models, researchers aim to evaluate potential medical countermeasures and treatments before they are tested in humans. Patients may benefit from advancements in therapies that arise from these models, as they help identify effective interventions against infectious diseases.
Why it matters
Potential benefit: If successful, this research could lead to the development of new and effective treatments for infectious diseases.
How similar studies have gone: Other research has shown success in using pre-clinical models to develop treatments for infectious diseases, indicating that this approach is both tested and promising.
Where this research is happening
-
Texas Biomedical Research Institute
San Antonio, United States Active
Related research
Other NIH-funded projects on the same topics.
-
Targeting human HIV latency with super-enhancer RNA targets
A short, patient-friendly plan to explore how special RNA molecules in immune cells control HIV hiding in the body and how we might disrupt that to help control the virus.
-
Pathways to trigger protective MAIT cell responses against bacterial infections
A study to figure out which bacterial metabolite antigens activate MAIT cells through MR1 to defend against TB and tularemia.
-
IL-21 therapy to boost lung immunity in HIV/TB co-infection
A study tests an IL-21-based therapy added to HIV treatment to help the lungs control TB and reduce HIV persistence in people (or animal models that simulate them).
-
Focused ultrasound to open the blood-brain barrier and reduce HIV reservoirs in the brain
A new approach uses gentle ultrasound to temporarily open the brain’s protective barrier so HIV medicines can reach the brain and shrink hidden virus reservoirs in people living with HIV.
-
Macrophage biology and metabolism in TB infection
Researchers are studying human lung macrophages to understand how they regulate immune responses and support or limit tuberculosis infection, with the goal of improving treatments that help the body fight TB.
-
Understanding how genetics and immunity shape chikungunya brain disease
A research project uses genetically diverse mice to learn why chikungunya virus causes brain inflammation in some people and how immune responses contribute to this disease.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.